Site icon pharmaceutical daily

ObsEva sets up interim CFO

Switzerland-based ObsEva SA has nominated Fabien de Ladonchamps, Vice President Corporate Affairs & Finance, as interim Chief Financial Officer and member of the Executive Committee.

This nomination came in place after the resignation of Tim Adams, effective close of business April 10, 2020. Tim Adams has served as CFO of ObsEva since January 2017 and is departing the Company to pursue a new opportunity.

Ernest Loumaye, CEO and Co-Founder of ObsEva, said: “On behalf of the Board of Directors and Executive team, I would like to thank Tim for his contributions to the Company and leadership during his tenure at ObsEva.  We would also like to thank Fabien for assuming this extended responsibility and his willingness to lead our financial operations. Fabien joined ObsEva in 2013 as a senior finance executive and has been involved in all aspects of the Company’s operations. I wish both continued success in their new positions.”

Exit mobile version